Other
Other income, net (Note 6)
Pfizer Other income, net (Note 6) increased by 80.9% to -$861.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from -$953.00M to -$861.00M. Over 3 years (FY 2021 to FY 2025), Other income, net (Note 6) shows a downward trend with a 11.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryOther
SignalHigher is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
Positive values indicate non-core gains, while negative values indicate non-core losses or interest burdens.
Detailed definition
This captures income or expenses that are not part of the company's core business operations, such as interest income, f...
Peer comparison
Standard line item found in the non-operating section of the income statement for most corporations.
Metric ID:
other_other_nonoperating_income_expenseHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.34B | $1.70B | $835.00M | -$350.00M | -$772.00M | $59.00M | $0.00 | -$275.00M | $75.00M | -$181.00M | -$680.00M | -$1.11B | -$243.00M | -$2.36B | -$953.00M | -$739.00M | -$517.00M | -$4.51B | -$861.00M |
| QoQ Change | — | +26.3% | -50.8% | -141.9% | -120.6% | +107.6% | -100.0% | — | +127.3% | -341.3% | -275.7% | -62.8% | +78.0% | -870.4% | +59.6% | +22.5% | +30.0% | -773.1% | +80.9% |
| YoY Change | — | — | — | — | -157.5% | -96.5% | -100.0% | +21.4% | +109.7% | -406.8% | -147.3% | <-999% | -34.3% | — | -40.1% | +33.2% | -112.8% | -91.4% | +9.7% |
Range-$4.51B – $1.70B
CAGR-9.4%
Avg YoY Growth-184.9%
Median YoY Growth-94.0%
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Biopharma | $90.00M | $128.00M | $51.00M | $78.00M | $115.00M | $120.00M | $268.00M | $116.00M |
| Total | -$1.11B | -$243.00M | -$2.36B | -$953.00M | -$739.00M | -$517.00M | -$4.51B | -$861.00M |
Other income, net (Note 6) at Other Companies
Frequently Asked Questions
- What is Pfizer's other income, net (note 6)?
- Pfizer (PFE) reported other income, net (note 6) of -$861.00M in Q1 2026.
- How has Pfizer's other income, net (note 6) changed year-over-year?
- Pfizer's other income, net (note 6) increased by 9.7% year-over-year, from -$953.00M to -$861.00M.
- What is the long-term trend for Pfizer's other income, net (note 6)?
- Over 3 years (2021 to 2025), Pfizer's other income, net (note 6) has grown at a 11.3% compound annual growth rate (CAGR), from $4.88B to -$6.72B.
- What does other income, net (note 6) mean?
- Financial gains or losses that fall outside of the company's primary business activities.